CD20 peptide SLFLGILSV (HLA-A*0201)

IBA Lifescience Kontakt z doradcą
Single peptide synthesized as presented by the MHC class I allele
CD20 peptide SLFLGILSV (HLA-A*0201)

CD20 peptide SLFLGILSV (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from B cell antigen CD20 is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be used for targeted in vitro generation and expansion of antigen-specific CD8+ T cells. The peptides were purified by HPLC using a water and acetonitrile gradient and are endotoxin-free.

Specifications

  • Form: Lyophilized powder
  • Peptide Sequence: SLFLGILSV
  • Possible Application: T cell stimulation
  • Purity: > 85%
  • Sterility: Sterile
  • MHC I Compatibility: HLA-A*0201

Podobne produkty

MHC I-Strep H-2 Db; p56 (AGPHNDMEI)

MHC I-Strep H-2 Db; p56 (AGPHNDMEI)

IBA Lifescience
Więcej
CD3 Fab-TACS® Agarose Column Starter Kit, mouse

CD3 Fab-TACS® Agarose Column Starter Kit, mouse

IBA Lifescience
Więcej
MHC I-Strep HLA-A*0201; gp100 (YLEPGPVTA)

MHC I-Strep HLA-A*0201; gp100 (YLEPGPVTA)

IBA Lifescience
Więcej